Boston Scientific, Guidant Close The Deal Following FTC Approval

Boston Scientific closed its $28 bil. acquisition of Guidant on April 21, one day after the Federal Trade Commission approved the deal - the largest medical device acquisition in history

More from Archive

More from Medtech Insight